Skip to main content
. 2018 Jan 5;9(11):9885–9906. doi: 10.18632/oncotarget.24009

Table 1. Human kinin B2R binding and pharmacological activities, distribution coefficient and cell permeability values of agents used in the study.

Agents / Code name Binding hB2R-HEK293T IC50 (nM) Bioassay hUV IC50 (nM) Distribution coefficient log D, n-octanol/PBS (pH 7.4) Cellular incorporation (pmol/106 cells)
15 min 4 h 24 h
HOE 140 5.3 ± 1.7* 3.8 ± 0.3* -3.06 0 0 0
FR 173657 37.0 ± 1.6* 6.0 ± 0.8* 2.89 116 139 185
d-Tat-HOE 140 (NG68) 5.2 ± 1.0 18.0 ± 4.0 -3.02 5 14 21
Cholic-HOE 140 (NG134) 19.0 ± 6.5 6.5 ± 2.5 0.21 13 22 63

Values are means ± s.e.m. *Data taken from ref. [34]. Binding assays were performed using living adherent HEK-293T cells transiently transfected with hB2R. Pharmacological activities of B2RAs were performed on human de-endothelized umbilical veins (hUV). Distribution coefficient of compounds between n-octanol and 0.1 M sodium phosphate buffer, pH 7.4, was determined by the shake flask methodology. Compound content of the aqueous and octanol phases was quantified by RP-HPLC. Cellular incorporation of B2RAs within MDA-MB-231 cells were assessed using a tandem quadrupole LC-MS/MS system. Results are the average of two independent assays.